Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Dr. Reddy's Laboratories Ltd.
NSE: DRREDDY
|
BSE: 500124
|
ISIN: INE089A01031
|
Industry: Pharmaceuticals
US FDA Observation
|
Turnaround Potential
1291.3000
40.70
(
3.25
%)
NSE
Sep 09, 2025
15:31 PM
26.60% Gain from 52W Low
Volume:
1.6M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Dr. Reddy's Laboratories Ltd.
17 May 2021
US FDA Observation
1291.30
3.25%
Result Update:Dr Reddys Labs
Buy:
Dr. Reddy's Laboratories Ltd.
by
Axis Direct
Target: 5700
Axis Direct
Therefore, we recommend Buy with a revised target price of INR 5,700.
Dr. Reddy's Laboratories Ltd.'s price crossed above 100Day SMA today
More from Dr. Reddy's Laboratories Ltd.
Recommended
Five stocks to buy from analysts this week - September 9, 2025
The Baseline |
09 Sep 2025, 05:38PM
Market closes higher, Waaree Renewable bags a Rs 1,252 crore solar project
Trendlyne Marketwatch |
09 Sep 2025, 04:00PM
Dr Reddy’s Labs struggles in its biggest market
|
18 Aug 2021